Elevated levels of soluble ICAM-1 in serum of patients with acute myeloid leukemia undergoing bone marrow transplantation.
Serum soluble ICAM-1 concentrations were measured in 10 patients with or without chronic graft-vs.-host disease (GVHD) after allogeneic bone marrow transplantation. The serum soluble ICAM-1 levels in the patients with chronic GVHD were significantly higher than that in the patients without chronic GVHD. The data indicated that serum soluble ICAM-1 is a useful parameter for predicting chronic GVHD.
Maeda
Y
Y
Third Department of Internal Medicine, Kinki University School of Medicine, Osaka, Japan.
Chihara
J
J
Horiuchi
F
F
Miyatake
J
J
Tatsumi
Y
Y
Urase
F
F
Irimajiri
K
K
Nakajima
S
S
Horiuchi
A
A
D000208:Acute Disease; D016026:Bone Marrow Transplantation; D006086:Graft vs Host Disease / Q000097:blood; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000097:blood*; D007951:Leukemia, Myeloid / Q000097:blood* / Q000601:surgery*; D012016:Reference Values; D012995:Solubility
D018799:Intercellular Adhesion Molecule-1